Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

International Union of Basic and Clinical Pharmacology. LXXXVI. Orexin Receptor Function, Nomenclature and Pharmacology
Anthony L. Gotter, Andrea L. Webber, Paul J. Coleman, et al.
Pharmacological Reviews (2012) Vol. 64, Iss. 3, pp. 389-420
Closed Access | Times Cited: 154

Showing 26-50 of 154 citing articles:

Discovery of 5′′‐Chloro‐N‐[(5,6‐dimethoxypyridin‐2‐yl)methyl]‐2,2′:5′,3′′‐terpyridine‐3′‐carboxamide (MK‐1064): A Selective Orexin 2 Receptor Antagonist (2‐SORA) for the Treatment of Insomnia
Anthony J. Roecker, Swati P. Mercer, John D. Schreier, et al.
ChemMedChem (2013) Vol. 9, Iss. 2, pp. 311-322
Closed Access | Times Cited: 62
OREXIN 1 AND 2 RECEPTOR INVOLVEMENT IN CO2-INDUCED PANIC-ASSOCIATED BEHAVIOR AND AUTONOMIC RESPONSES
Philip L. Johnson, Lauren M. Federici, Stephanie D. Fitz, et al.
Depression and Anxiety (2015) Vol. 32, Iss. 9, pp. 671-683
Open Access | Times Cited: 62
Attenuated orexinergic signaling underlies depression-like responses induced by daytime light deficiency
Sean Deats, Widya Adidharma, Joseph S. Lonstein, et al.
Neuroscience (2014) Vol. 272, pp. 252-260
Open Access | Times Cited: 59
Orexin/Hypocretin Based Pharmacotherapies for the Treatment of Addiction: DORA or SORA?
Shaun Yon‐Seng Khoo, Robyn M. Brown
CNS Drugs (2014) Vol. 28, Iss. 8, pp. 713-730
Open Access | Times Cited: 58
Orexin, orexin receptor antagonists and central cardiovascular control
Pascal Carrive
Frontiers in Neuroscience (2013) Vol. 7
Open Access | Times Cited: 57
Therapeutics development for addiction: Orexin-1 receptor antagonists
David A. Perrey, Yanan Zhang
Brain Research (2018) Vol. 1731, pp. 145922-145922
Open Access | Times Cited: 55
Dual orexin receptor antagonist 12 inhibits expression of proteins in neurons and glia implicated in peripheral and central sensitization
Ryan Cady, Jennifer E. Denson, Logan Sullivan, et al.
Neuroscience (2014) Vol. 269, pp. 79-92
Closed Access | Times Cited: 53
Suvorexant for the treatment of insomnia
Laura H. Jacobson, Gabrielle E. Callander, Daniël Hoyer
Expert Review of Clinical Pharmacology (2014) Vol. 7, Iss. 6, pp. 711-730
Closed Access | Times Cited: 52
Orexin 2 receptor regulation of the hypothalamic–pituitary–adrenal (HPA) response to acute and repeated stress
Laura A. Grafe, Darrell Eacret, Sandra Luz, et al.
Neuroscience (2017) Vol. 348, pp. 313-323
Open Access | Times Cited: 50
Targeting orexin receptors: Recent advances in the development of subtype selective or dual ligands for the treatment of neuropsychiatric disorders
Alessandro Bonifazi, Fabio Del Bello, Gianfabio Giorgioni, et al.
Medicinal Research Reviews (2023) Vol. 43, Iss. 5, pp. 1607-1667
Closed Access | Times Cited: 13
The Orexin System and Its Impact on the Autonomic Nervous and Cardiometabolic System in Post-Acute Sequelae of COVID-19
Jana Ruhrländer, Styliani Syntila, Elisabeth Schieffer, et al.
Biomedicines (2025) Vol. 13, Iss. 3, pp. 545-545
Open Access
The hypocretins and the reward function: what have we learned so far?
Benjamin Boutrel, Nadia Steiner, Olivier Halfon
Frontiers in Behavioral Neuroscience (2013) Vol. 7
Open Access | Times Cited: 47
Orexin/hypocretin and dysregulated eating: Promotion of foraging behavior
Jessica R. Barson
Brain Research (2018) Vol. 1731, pp. 145915-145915
Open Access | Times Cited: 46
Hypocretin receptor 1 blockade preferentially reduces high effort responding for cocaine without promoting sleep
Zachary D. Brodnik, David L. Bernstein, Courtney D. Prince, et al.
Behavioural Brain Research (2015) Vol. 291, pp. 377-384
Open Access | Times Cited: 46
Orexin and Central Modulation of Cardiovascular and Respiratory Function
Pascal Carrive, Tomoyuki Kuwaki
Current topics in behavioral neurosciences (2016), pp. 157-196
Open Access | Times Cited: 45
Orexin receptor antagonists for the treatment of insomnia and potential treatment of other neuropsychiatric indications
W. Joseph Herring, Thomas Roth, Andrew D. Krystal, et al.
Journal of Sleep Research (2018) Vol. 28, Iss. 2
Closed Access | Times Cited: 44
Differential sleep-promoting effects of dual orexin receptor antagonists and GABAAreceptor modulators
Anthony L. Gotter, Susan L. Garson, Joanne Stevens, et al.
BMC Neuroscience (2014) Vol. 15, Iss. 1
Open Access | Times Cited: 42
Role of the Orexin System on the Hypothalamus-Pituitary-Thyroid Axis
Antonietta Messina, Carolina De Fusco, Vincenzo Monda, et al.
Frontiers in Neural Circuits (2016) Vol. 10
Open Access | Times Cited: 40
Dim Light at Night and Constant Darkness: Two Frequently Used Lighting Conditions That Jeopardize the Health and Well-being of Laboratory Rodents
Mónica M. C. González
Frontiers in Neurology (2018) Vol. 9
Open Access | Times Cited: 40
The Orexin receptors: Structural and anti-tumoral properties
Alain Couvineau, Pascal Nicole, Valérie Gratio, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 20
Orexin Receptor Antagonists and Insomnia
Xin Wu, Tao Xue, Zhouqing Chen, et al.
Current Psychiatry Reports (2022) Vol. 24, Iss. 10, pp. 509-521
Closed Access | Times Cited: 20
Orexin type 1 receptor antagonism in rat locus coeruleus prevents the analgesic effect of intra-LC met-enkephalin microinjection
S. Mohammad Ahmadi‐Soleimani, Hossein Azizi, Javad Mirnajafi‐Zadeh, et al.
Pharmacology Biochemistry and Behavior (2015) Vol. 136, pp. 102-106
Closed Access | Times Cited: 40
The role of orexin in post-stroke inflammation, cognitive decline, and depression
Juhyun Song, Eosu Kim, Chul Hoon Kim, et al.
Molecular Brain (2015) Vol. 8, Iss. 1
Open Access | Times Cited: 38
Blockade of orexin type-1 receptors in locus coeruleus nucleus attenuates the development of morphine dependency in rats
Sayed Yousof Mousavi, Hossein Azizi, Javad Mirnajafi‐Zadeh, et al.
Neuroscience Letters (2014) Vol. 578, pp. 90-94
Closed Access | Times Cited: 38
Differential contribution of orexin receptors within the ventral tegmental area to modulation of persistent inflammatory pain
Somayeh Ezzatpanah, Vahab Babapour, Abbas Haghparast
European Journal of Pain (2016) Vol. 20, Iss. 7, pp. 1090-1101
Closed Access | Times Cited: 38

Scroll to top